artesunic acid has been researched along with imatinib mesylate in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Madrid, EM; Mahanty, S; Nash, TE | 1 |
| Colah, R; Ghosh, K; Pathak, V | 1 |
| Kupferschmidt, K | 1 |
| Rein, T | 1 |
| Akbarzadeh, A; Amani, B; Shabestan, R; Zareei, M; Zareei, N; Zareei, S | 1 |
2 review(s) available for artesunic acid and imatinib mesylate
| Article | Year |
|---|---|
Harnessing autophagy to fight SARS-CoV-2: An update in view of recent drug development efforts.
Topics: Antidepressive Agents; Antiviral Agents; Artesunate; Autophagy; Chloroquine; COVID-19 Drug Treatment; Drug Development; Drug Repositioning; Endoplasmic Reticulum; Endosomes; Humans; Hydroxychloroquine; Imatinib Mesylate; Infliximab; Intracellular Membranes; Ivermectin; Macrolides; Middle East Respiratory Syndrome Coronavirus; Niclosamide; Pandemics; RNA, Viral; SARS-CoV-2; Virus Replication | 2022 |
Artesunate, imatinib, and infliximab in COVID-19: A rapid review and meta-analysis of current evidence.
Topics: Artesunate; COVID-19 Drug Treatment; Humans; Imatinib Mesylate; Infliximab; SARS-CoV-2 | 2022 |
3 other study(ies) available for artesunic acid and imatinib mesylate
| Article | Year |
|---|---|
Quantitative screening for anticestode drugs based on changes in baseline enzyme secretion by Taenia crassiceps.
Topics: Alkaline Phosphatase; Animals; Anticestodal Agents; Artemisinins; Artesunate; Benzamides; Epilepsy; Glucose-6-Phosphate Isomerase; Humans; Imatinib Mesylate; Neurocysticercosis; Nitro Compounds; Parasitic Sensitivity Tests; Piperazines; Praziquantel; Protein Kinase Inhibitors; Pyrimidines; Taenia; Thiazoles | 2013 |
Tyrosine kinase inhibitors: New class of antimalarials on the horizon?
Topics: Antimalarials; Artemisinins; Artesunate; Dose-Response Relationship, Drug; Drug Interactions; Erythrocytes; Humans; Imatinib Mesylate; Inhibitory Concentration 50; Plasmodium falciparum; Protein Kinase Inhibitors; Protein-Tyrosine Kinases | 2015 |
WHO relaunches global drug trial with three new candidates.
Topics: Antiviral Agents; Artesunate; COVID-19 Drug Treatment; Humans; Imatinib Mesylate; Infliximab; Randomized Controlled Trials as Topic; World Health Organization | 2021 |